Tiaa Fsb trimmed its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 7.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,240 shares of the medical research company’s stock after selling 9,412 shares during the period. Tiaa Fsb’s holdings in Thermo Fisher Scientific were worth $23,128,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Covington Capital Management grew its position in Thermo Fisher Scientific by 0.9% in the 2nd quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock worth $374,000 after purchasing an additional 20 shares during the last quarter. Investment Centers of America Inc. grew its position in Thermo Fisher Scientific by 1.6% in the 2nd quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock worth $230,000 after purchasing an additional 21 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its position in Thermo Fisher Scientific by 0.4% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock worth $1,090,000 after purchasing an additional 23 shares during the last quarter. Azimuth Capital Management LLC grew its position in Thermo Fisher Scientific by 0.8% in the 1st quarter. Azimuth Capital Management LLC now owns 3,210 shares of the medical research company’s stock worth $493,000 after purchasing an additional 25 shares during the last quarter. Finally, Bienville Capital Management LLC grew its position in Thermo Fisher Scientific by 1.6% in the 2nd quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock worth $295,000 after purchasing an additional 27 shares during the last quarter. Institutional investors own 83.78% of the company’s stock.

Several analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 target price on the stock in a research report on Tuesday, October 31st. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. Deutsche Bank AG set a $226.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. Jefferies Group LLC reiterated a “hold” rating and set a $195.00 target price on shares of Thermo Fisher Scientific in a research report on Thursday, September 28th. Finally, The Goldman Sachs Group, Inc. assumed coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price on the stock. One investment analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $205.71.

WARNING: This news story was published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/11/17/thermo-fisher-scientific-inc-tmo-shares-sold-by-tiaa-fsb.html.

In other Thermo Fisher Scientific news, VP Seth H. Hoogasian sold 4,140 shares of the business’s stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $177.80, for a total value of $736,092.00. Following the completion of the transaction, the vice president now directly owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Daniel P. Shine sold 2,026 shares of the business’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total transaction of $366,645.22. Following the completion of the transaction, the insider now directly owns 20,682 shares of the company’s stock, valued at $3,742,821.54. The disclosure for this sale can be found here. Insiders have sold a total of 10,420 shares of company stock valued at $1,888,977 over the last three months. 0.49% of the stock is currently owned by insiders.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at $190.61 on Friday. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $201.20. The stock has a market cap of $75,591.64, a PE ratio of 20.72, a P/E/G ratio of 1.73 and a beta of 1.08. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period last year, the firm posted $2.03 EPS. The firm’s quarterly revenue was up 13.9% on a year-over-year basis. equities analysts predict that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.31%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.